Investment
Features
FeesSafety
Academy
More
Pluang+

Compare REX AI Equity Premium Income ETF (AIPI) vs Davita Inc (DVA) Price & Performance

REX AI Equity Premium Income ETFTrade
Davita IncTrade

Price performance (Past 24H)

Key statistics

REX AI Equity Premium Income ETF vs Davita Inc — how do they compare? REX AI Equity Premium Income ETF trades at $37.25, while Davita Inc trades at $179.02 (market cap $11.72B). The key difference: Davita Inc is trading nearer its 52-week high, REX AI Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.

AIPIDVA
Sector
Income / Options OverlayHealth
52-Week High
$44.93$240.96
52-Week Low
$32.45$103.87
Market Cap
$11.72B
Enterprise Value
$24.44B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

REX AI Equity Premium Income ETF

AIPI trades at $37.34, up 1.52% today, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The stock pays high weekly dividends, recently transitioning to this frequency to attract income investors. Key resistance lies at $38, with support at $36.

Outlook is mixed: high dividend yields near 35% offer income appeal, but sustainability concerns and structural risks from option-writing strategies pose challenges. Investors should weigh income benefits against potential NAV erosion if AI market momentum slows.

Davita Inc

DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.

The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About REX AI Equity Premium Income ETF

AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.

Read more on AIPI

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Read more on DVA